Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 17, 2018

FDA clears Medtronic’s Riptide device for acute ischemic stroke

Medtronic's Neurovascular business division has obtained clearance from the US Food and Drug Administration (FDA) for its Riptide Aspiration System to treat acute ischemic stroke.

Medtronic’s Neurovascular business division has obtained clearance from the US Food and Drug Administration (FDA) for its Riptide Aspiration System to treat acute ischemic stroke.

The Riptide Aspiration System includes the Arc Catheter, Riptide Aspiration Pump, Riptide Aspiration Tubing, and Riptide Collection Canister with intermediate tubing.

The system is intended to restore blood flow in blocked arteries of ischemic stroke patients by retrieving the clot through the Arc Catheter, which is inserted via an incision in the leg and up to the specific artery.

Riptide is used for the revascularisation of patients affected by acute ischemic stroke secondary to intracranial large vessel occlusive disease within eight hours of onset of the symptoms.

“The system can be used to treat patients who are not eligible or fail therapy with intravenous tissue plasminogen activator (IV tPA).”

The system can be used to treat patients who are not eligible or fail therapy with intravenous tissue plasminogen activator (IV tPA).

It expands Medtronic’s portfolio of revascularisation devices for acute ischemic stroke, including Solitaire with Parametric technology to restore blood flow and MindFrame Capture LP device to treat distal zone occlusions.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Medtronic Restorative Therapies Group Neurovascular business vice-president and general manager Stacey Pugh said: “Medtronic is committed to developing services and solutions that address healthcare needs by improving clinical and economic outcomes.

“We believe that the Riptide Aspiration System and Solitaire Revascularisation Device provide our customers with a comprehensive suite of products to choose from.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU